Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors
AssigneeAstraZeneca AB
InventorsMarcel Linschoten, Magnus Polla
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of Formula I, and pharmaceutically acceptable salts or solvates thereof, or solvates of such salts, which compounds inhibit carboxypeptidase U and thus can be used in the prevention and treatment of diseases associated with carboxypeptidase U. In further aspects, the invention relates to compounds of the invention for use in therapy; to processes for preparation of such new compounds; to pharmaceutical compositions containing at least one compound of the invention, or a pharmaceutically acceptable salt or solvate thereof, as active ingredient; and to the use of the active compounds in the manufacture of medicaments for the medical use indicated above.
Claims23
A compound of general Formula I
- or a pharmaceutically acceptable salt or solvate thereof, or a solvate of such a salt,
- wherein:
- R1 is selected from the group consisting of:
- C1-C6 alkyl, substituted with one or more basic groups, wherein the conjugate acid of said basic group has a pKa of from 1 to 15;
- cycloalkyl, substituted with one or more basic groups, wherein the conjugate acid of said basic group has a pKa of from 1 to 15;
- aromatic heterocyclyl, containing at least one nitrogen atom and substituted with one or more basic groups, wherein the conjugate acid of said basic group has a pKa of from 1 to 15;
- aliphatic heterocyclyl, containing at least one nitrogen atom;
- heterocyclyl, containing at least one hetero atom selected from S or O, and substituted with one or more basic groups, wherein the conjugate acid of said basic group has a pka of from 1-15;
- and
- aryl, substituted with one or more basic groups, wherein the conjugate acid of said basic group has a pKa of from 1 to 15;
- R2 is selected from the group consisting of H, methyl, halogen, and hydroxy;
- R3 is selected from the group consisting of COOR5, SO(OR5), SO3R5, P═O(OR5)2, B(OR5)2, P═OR5(OR5), tetrazole, and a carboxylic acid isostere;
- R4 represents a
- R5 is H, C1-C6 alkyl, or aryl;
- R6 is C1-C6 alkyl, aryl, cycloalkyl, heterocyclyl, or an optionally N-substituted
- H2N—C(Z)-CONH—C(Z)- or H2N—C(Z)- group;
- R7 is H or C1-C6 alkyl;
- X is C(Z)2;
- Y is C(Z)2 or a single bond;
- Z is independently selected from the group consisting of H, C1-C6 alkyl, aryl, cycloalkyl, and heterocyclyl.
5-17. (canceled)
Dependencies are inferred from the claim text.